Stanford launches clinical trial involving Paxlovid for long Covid patients

0


Stanford launches clinical trial involving Paxlovid for long Covid patients – CBS San Francisco


Watch CBS News



New research from the Veterans Health Administration found that patients taking the oral antiviral pill Paxlovid may reduce their risk of developing long Covid. Dr. Linda Geng, co-director of the Stanford long Covid clinic, discusses how effective that may be, and how long Covid could also cause parts of the body to age

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.




Source link

Leave A Reply

Your email address will not be published.